https://orcid.org/0000-0001-8376-8311
References
- Alvarez-Sanchez R, Montavon F, Hartung T, Pähler A. 2006. Thiazolidinedione bioactivation: a comparison of the bioactivation potentials of troglitazone, rosiglitazone, and pioglitazone using stable isotope-labeled analogues and liquid chromatography tandem mass spectrometry. Chem Res Toxicol. 19(8):1106–1116. doi:10.1021/tx050353h.
- EMA 2008. ICH Topic M 3 (R2). Note for the guidance on non-clinical safety studies for the conduct of human clinical trials and marketing authorisation for pharmaceuticals.
- FDA 2020. Safety testing of drug metabolites: guidance for industry.
- Isin E. 2023. Unusual biotransformation reactions of drugs and drug candidates. Drug Metab Dispos. 51(4):413–426. doi:10.1124/dmd.121.000744.
- Gharibkandi NA, Molavipordanjani S, Mardanshahi A, Hosseinimehr SJ. 2022. The influence of kidneys ion transport inhibitors on the pharmacokinetic and tumor uptake behaviors of a HER2-targeted small size radiolabeled peptide. Curr Drug Metab. 23(1):82–87. doi:10.2174/1389200223666220113101004.
- James AD, Marvalin C, Luneau A, Meissner A, Camenisch G. 2017. Comparison of 19F NMR and 14C measurements for the assessment of ADME of BYL719 (Alpelisib) in humans. Drug Metab Dispos. 45(8):900–907. doi:10.1124/dmd.117.075424.
- Nock BA, Maina T, Krenning EP, de Jong M. 2014. To serve and protect’: enzyme inhibitors as radiopeptide escorts promote tumor targeting. J Nucl Med. 55(1):121–127. doi:10.2967/jnumed.113.129411.
- Ocak M, Antretter M, Knopp R, Kunkel F, Petrik M, Bergisadi N, Decristoforo C. 2010. Full automation of (68)Ga labelling of DOTA-peptides including cation exchange prepurification. Appl Radiat Isot. 68(2):297–302. doi:10.1016/j.apradiso.2009.10.006.
- Pearson D, Garnier M, Luneau A, James AD, Walles M. 2019. 19F-NMR-based determination of the absorption, metabolism and excretion of the oral phosphatidylinositol-3-kinase (PI3K) delta inhibitor leniolisib (CDZ173) in healthy volunteers. Xenobiotica. 49(8):953–960. doi:10.1080/00498254.2018.1523488.
- Singh RSP, Walker GS, Kadar EP, Cox LM, Eng H, Sharma R, Bergman AJ, Van Eyck L, Hackman F, Toussi SS, et al. 2022. Metabolism and excretion of Nirmatrelvir in humans using quantitative fluorine nuclear magnetic resonance spectroscopy: a novel approach for accelerating drug development. Clin Pharma and Therapeutics. 112(6):1201–1206. doi:10.1002/cpt.2683.
- Tzouros M, Pähler A. 2009. A targeted proteomics approach to the identification of peptides modified by reactive metabolites. Chem Res Toxicol. 22(5):853–862. doi:10.1021/tx800426x.
- Weston DJ, Dave M, Colizza K, Thomas S, Tomlinson L, Gregory R, Beaumont C, Pirhalla J, Dear GJ. 2022. A discovery biotransformation strategy: combining in silico tools with high-resolution mass spectrometry and software-assisted data analysis for high-throughput metabolism. Xenobiotica. 52(8):928–942. doi:10.1080/00498254.2022.2136042.